Back to top

Alnylam price target raised to $468 from $420 at Raymond James

Raymond James raised the firm’s price target on Alnylam (ALNY) to $468 from $420 and keeps an Outperform rating on the shares. Ionis’ (IONS) failed...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Alnylam Pharmaceuticals, Inc. (ALNY)

Ionis Pharmaceuticals, Inc. (IONS)